These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 11717147)

  • 1. The pleiotropic nature of the vascular PPAR gene regulatory pathway.
    Kelly DP
    Circ Res; 2001 Nov; 89(11):935-7. PubMed ID: 11717147
    [No Abstract]   [Full Text] [Related]  

  • 2. Activation of peroxisome proliferator-activated receptor gamma inhibits osteoprotegerin gene expression in human aortic smooth muscle cells.
    Fu M; Zhang J; Lin Yg Yg; Zhu X; Willson TM; Chen YE
    Biochem Biophys Res Commun; 2002 Jun; 294(3):597-601. PubMed ID: 12056809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overview. PPAR and cardiovascular risk.
    Fruchart JC
    J Cardiovasc Risk; 2001 Aug; 8(4):185-6. PubMed ID: 11550995
    [No Abstract]   [Full Text] [Related]  

  • 4. PPAR alpha, fibrates, lipid metabolism and inflammation.
    Duval C; Fruchart JC; Staels B
    Arch Mal Coeur Vaiss; 2004 Jun; 97(6):665-72. PubMed ID: 15283041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FXR-mediated regulation of angiotensin type 2 receptor expression in vascular smooth muscle cells.
    Zhang Q; He F; Kuruba R; Gao X; Wilson A; Li J; Billiar TR; Pitt BR; Xie W; Li S
    Cardiovasc Res; 2008 Feb; 77(3):560-9. PubMed ID: 18006431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelin-1-induced cardiac hypertrophy is inhibited by activation of peroxisome proliferator-activated receptor-alpha partly via blockade of c-Jun NH2-terminal kinase pathway.
    Irukayama-Tomobe Y; Miyauchi T; Sakai S; Kasuya Y; Ogata T; Takanashi M; Iemitsu M; Sudo T; Goto K; Yamaguchi I
    Circulation; 2004 Feb; 109(7):904-10. PubMed ID: 14967736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Peroxisome proliferator-activated receptors (PPAR) in pathophysiology of the circulatory system and prospective use of agonists of these receptors in therapy].
    Bełtowski J; Wójcicka G; Jamroz A
    Postepy Hig Med Dosw; 2003; 57(2):199-217. PubMed ID: 12866356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cells.
    Marx N; Duez H; Fruchart JC; Staels B
    Circ Res; 2004 May; 94(9):1168-78. PubMed ID: 15142970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of the growth arrest and DNA damage-inducible gene 45 (GADD45) by peroxisome proliferator-activated receptor gamma in vascular smooth muscle cells.
    Bruemmer D; Yin F; Liu J; Berger JP; Sakai T; Blaschke F; Fleck E; Van Herle AJ; Forman BM; Law RE
    Circ Res; 2003 Aug; 93(4):e38-47. PubMed ID: 12881480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging roles of PPARs in inflammation and immunity.
    Daynes RA; Jones DC
    Nat Rev Immunol; 2002 Oct; 2(10):748-59. PubMed ID: 12360213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Activation of transcriptional factor by signal transduction: overview].
    Kato S
    Tanpakushitsu Kakusan Koso; 2000 Jun; 45(9 Suppl):1523-5. PubMed ID: 10879129
    [No Abstract]   [Full Text] [Related]  

  • 12. Down-regulation of STAT5b transcriptional activity by ligand-activated peroxisome proliferator-activated receptor (PPAR) alpha and PPARgamma.
    Shipley JM; Waxman DJ
    Mol Pharmacol; 2003 Aug; 64(2):355-64. PubMed ID: 12869640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 15-Deoxy-Delta12,14-prostaglandin J2 and thiazolidinediones transactivate epidermal growth factor and platelet-derived growth factor receptors in vascular smooth muscle cells.
    Ichiki T; Tokunou T; Fukuyama K; Iino N; Masuda S; Takeshita A
    Biochem Biophys Res Commun; 2004 Oct; 323(2):402-8. PubMed ID: 15369766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Peroxisome proliferator activated receptors PPARs: their role in carbohydrate and lipid metabolism].
    Andrééva-Gatéva P
    Ann Biol Clin (Paris); 2003; 61(3):295-303. PubMed ID: 12805006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisome proliferator-activated receptor-gamma-independent repression of collagenase gene expression by 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid and prostaglandin 15-deoxy-delta(12,14) J2: a role for Smad signaling.
    Mix KS; Coon CI; Rosen ED; Suh N; Sporn MB; Brinckerhoff CE
    Mol Pharmacol; 2004 Feb; 65(2):309-18. PubMed ID: 14742672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Humic acid induces the expression of ox-LDL receptor in HL-60 cells through activation of PPAR-gamma.
    Huang YL; Huang TS; Lu FJ
    Bull Environ Contam Toxicol; 2003 Aug; 71(2):429-36. PubMed ID: 14560399
    [No Abstract]   [Full Text] [Related]  

  • 17. Teaching resources. Nuclear receptors.
    Taneja R
    Sci STKE; 2005 May; 2005(286):tr17. PubMed ID: 15928334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of the peroxisome proliferator-activated receptors (PPARS) in the regulation of lipids and inflammation control].
    Bocher V; Chinetti G; Fruchart JC; Staels B
    J Soc Biol; 2002; 196(1):47-52. PubMed ID: 12134632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mechanism of vascular calcification].
    Son BK; Akishita M
    Clin Calcium; 2007 Mar; 17(3):319-24. PubMed ID: 17339734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous, bidirectional inhibitory crosstalk between PPAR and STAT5b.
    Shipley JM; Waxman DJ
    Toxicol Appl Pharmacol; 2004 Sep; 199(3):275-84. PubMed ID: 15364543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.